Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according ...

Patients who responded positively to shunt treatment experienced more beneficial changes in their heart's structure and function compared with nonresponders. After 2 years of follow-up, a post hoc ...

FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

ATLANTA -- An interatrial shunt failed to provide a clinical benefit to people with heart failure (HF) overall in the RELIEVE-HF trial, though actual harm or benefit seemed to hinge on the patient's ...

Please provide your email address to receive an email when new articles are posted on . Interatrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Advisers to the Food and Drug Administration on Wednesday ...

Jimmy McMillan, 69, of West Columbia felt his health growing worse as his heart failure progressed. “I would have trouble just walking down to the mailbox and back without having to stop and catch my ...

SHREVEPORT, La. -- LSU Health Shreveport is one of only 25 sites around the country participating in a major clinical trial for individuals with stiff heart syndrome. About half of of patients with ...

Heart failure with preserved ejection fraction (HFpEF) can arise from a range of genetic and physiological triggers, but the common denominator—elevated left atrial (LA) pressure—has spawned a host of ...